Quintrio
Home

Stock overview

Basel Medical Group Ltd Ordinary Shares

BMGL

Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. The services provided by clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women's health and neurosurgical conditions and clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services. Key revenue is generated from Singapore.

Last trade $0.3467
Day change +$0.0444 (+14.69%)
Day range $0.25 – $0.519
Volume 60,744,931
Market cap $4M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for BMGL.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for BMGL.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement

Basel Medical Group Ltd (BMGL) announced on July 10, 2026 that it has regained compliance with Nasdaq's minimum bid price rule of $1.00 per share. The company had been notified of non-compliance in January 2026 but successfully maintained the required minimum closing bid price for 10 consecutive business days from June 23-July 7, 2026.

GlobeNewswire Inc.

BMGL to Effect Reverse Share Split on June 22, 2026

Basel Medical Group Ltd (Nasdaq: BMGL), a Singapore-based medical clinic operator, announced a 1-for-12 reverse stock split effective June 22, 2026, to comply with Nasdaq's minimum bid price requirement of $1 per share. The consolidation will reduce outstanding shares from approximately 18.8 million to 1.6 million shares.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Jun 22, 20261-for-12reverse split